相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic Potential of Afatinib inNRG1Fusion-Driven Solid Tumors: A Case Series
Jacques Cadranel et al.
ONCOLOGIST (2021)
Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer
Zeda Zhang et al.
CANCER CELL (2020)
Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases
Mohamed Alhamar et al.
HISTOPATHOLOGY (2020)
Emerging Allosteric Mechanism of EGFR Activation in Physiological and Pathological Contexts
Chung-Jung Tsai et al.
BIOPHYSICAL JOURNAL (2019)
Detection of NRG1 Gene Fusions in Solid Tumors
Sushma Jonna et al.
CLINICAL CANCER RESEARCH (2019)
NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma
Martin R. Jones et al.
CLINICAL CANCER RESEARCH (2019)
Detection of Novel NRG1, EGFR, and MET Fusions in Lung Adenocarcinomas in the Chinese Population
Yunjian Pan et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Resistance Mechanisms to Targeted Therapies in ROS1(+) and ALK(+) Non-small Cell Lung Cancer
Caroline E. McCoach et al.
CLINICAL CANCER RESEARCH (2018)
Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers
Alexander Drilon et al.
CANCER DISCOVERY (2018)
NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
Christoph Heining et al.
CANCER DISCOVERY (2018)
Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression
Domenico Trombetta et al.
Oncotarget (2018)
HER3 signaling and targeted therapy in cancer
Rosalin Mishra et al.
ONCOLOGY REVIEWS (2018)
Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3
Nadege Gaborit et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung
Dong Hoon Shin et al.
ONCOTARGET (2016)
VAMP2-NRG1 Fusion Gene is a Novel Oncogenic Driver of Non-Small-Cell Lung Adenocarcinoma
Yeonjoo Jung et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Molecular Pathways: Targeting NRG1 Fusions in Lung Cancer
Lynnette Fernandez-Cuesta et al.
CLINICAL CANCER RESEARCH (2015)
Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
Takashi Nakaoku et al.
CLINICAL CANCER RESEARCH (2014)
Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes
Saravana M. Dhanasekaran et al.
NATURE COMMUNICATIONS (2014)
CD74-NRG1 Fusions in Lung Adenocarcinoma
Lynnette Fernandez-Cuesta et al.
CANCER DISCOVERY (2014)
Differential distribution of neuregulin in human brain and spinal fluid
Mayk S. Pankonin et al.
BRAIN RESEARCH (2009)
ErbB receptors and signaling pathways in cancer
Nancy E. Hynes et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Neuregulin-1, a Key Axonal Signal that Drives Schwann Cell Growth and Differentiation
Carmen Birchmeier et al.
GLIA (2008)
Neuregulin 1 in neural development, synaptic plasticity and schizophrenia
Lin Mei et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors
Oh Bin Kwon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A. Tomlins et al.
NATURE (2007)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRGI gene
J Adélaïde et al.
GENES CHROMOSOMES & CANCER (2003)
Back signaling by the Nrg-1 intracellular domain
JX Bao et al.
JOURNAL OF CELL BIOLOGY (2003)
Neuregulins: functions, forms, and signaling strategies
DL Falls
EXPERIMENTAL CELL RESEARCH (2003)
Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation
SS Hobbs et al.
ONCOGENE (2002)
分享论文
